University of Arizona researchers have identified compounds in cannabis that may deliver significant pain relief while bypassing the psychoactive effects that make the drug controversial. The breakthrough focuses on terpenes, the aromatic molecules responsible for a plant's smell and taste, and suggests a new pathway for treating fibromyalgia and post-operative pain.
The study, published in Pharmacological Reports, tested four terpenes commonly found in cannabis: geraniol, linalool, beta-caryophyllene, and alpha-humulene. In laboratory models, all four showed substantial pain-relieving effects, with geraniol proving most potent. Unlike THC, these compounds produce no high, making them a cleaner option for patients seeking relief without intoxication.
"Terpenes are not a good option for reducing acute pain like stubbing your toe or touching a hot stove, but we are seeing significant reductions in pain when terpenes are used for chronic or pathological pain," said John Streicher, a pharmacology professor at the university's College of Medicine and a member of the Comprehensive Center for Pain & Addiction. This distinction matters: the compounds appear tailored for long-term conditions rather than sudden injury.
A Potential Game-Changer for Fibromyalgia
Fibromyalgia remains notoriously difficult to treat. The condition affects muscles and soft tissues throughout the body and impacts roughly 4 million American adults, with women accounting for the majority of cases. The medical establishment has struggled to develop effective therapies for a disorder whose underlying mechanisms are still poorly understood.
"There isn't much understanding of what the pain state is, and there are not a lot of great options for treating it," Streicher said. "Our findings show that terpenes may be a viable treatment option for fibromyalgia pain, which could potentially have a large impact and make a difference for an under-treated population."
The research also examined how terpenes might help patients recovering from surgery. Post-operative pain occupies unusual territory between acute and chronic conditions. While temporary, surgery triggers inflammation and heightened sensitivity in the body's pain pathways, creating significant discomfort that can complicate recovery.
Current treatment relies heavily on opioids, which effectively manage post-operative pain but carry risks. "Opioids can cause constipation that can increase the chances of post-surgical complications such as adhesions," Streicher noted. "We are always looking for better options, and this study suggests that terpenes could be a novel therapeutic for post-operative pain."
The scale of the need is substantial. Roughly 310 million major surgical procedures occur worldwide annually, underscoring demand for safer pain-management alternatives.
The terpenes appear to work through a specific biological pathway involving the adenosine A2a receptor, the same target that caffeine blocks. This discovery hints that terpenes might also have sedative properties, a possibility researchers say warrants deeper investigation in future studies.
Todd Vanderah, director of the Comprehensive Center for Pain & Addiction at U of A Health Sciences, emphasized the broader significance of exploring nature's chemistry. "There are hundreds of unique chemicals that plants make, including the Cannabis plant, that are undiscovered," Vanderah said. He pointed to semaglutide, a medication derived from Gila monster venom that became known as Ozempic, as proof that natural product research yields practical medical breakthroughs.
The research team included Caleb Seekins, a former undergraduate biochemistry student now in medical school; Alyssa Welborn, who earned a Bachelor of Science in Pharmaceutical Sciences in 2024; and Abigail Schwarz, who completed her doctorate in Streicher's lab that same year. The National Institutes of Health provided funding for the work.
Author Jessica Williams: "This is the kind of research that could finally give fibromyalgia patients real alternatives instead of drugs that barely work or make recovery worse."
Comments